排序方式：
1.The Role of Hydrogen Sulfide on Cardiovascular Homeostasis: An Overview with Update on Immunomodulation
Pan, LL, Qin, M, Liu
More...
Pan, LL, Qin, M, Liu, XH, Zhu, YZ
Less
FRONTIERS IN PHARMACOLOGY[1663-9812],
Published 2017,
Volume 8,
Issue SEP,
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 79
2023影響因子:
4.4
发表年影響因子:
3.831
2.An Update on AMPK in Hydrogen Sulfide Pharmacology
Wang, MJ, Tang, WB,
More...
Wang, MJ, Tang, WB, Zhu, YZ
Less
FRONTIERS IN PHARMACOLOGY[1663-9812],
Published 2017,
Volume 8,
Issue NOV,
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 29
2023影響因子:
4.4
发表年影響因子:
3.831
3.Anti-hypercholesterolemic Effects and a Good Safety Profile of SCM-198 in Animals: From ApoE Knockout Mice to Rhesus Monkeys
Suguro, R, Chen, SY,
More...
Suguro, R, Chen, SY, Yang, D, Yang, ZY, Miao, L, Wu, WJ, Zeng, W, Liu, XH, Zhu, YZ
Less
FRONTIERS IN PHARMACOLOGY[1663-9812],
Published 2018,
Volume 9,
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 17
2023影響因子:
4.4
发表年影響因子:
3.845
4.Epigenetics and Vascular Senescence–Potential New Therapeutic Targets?
Ding, Qian, Zhu, Yi
More...
Ding, Qian, Zhu, Yi Zhun, Shao, Chunhong, Rose, Peter
Less
Frontiers in Pharmacology[1663-9812],
Published 2020,
Volume 11,
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 14
2023影響因子:
4.4
发表年影響因子:
5.811
5.UGT1A1 rs4148323 A Allele is Associated With Increased 2-Hydroxy Atorvastatin Formation and Higher Death Risk in Chinese Patients With Coronary Artery Disease
Lei, HP, Qin, M, Cai
More...
Lei, HP, Qin, M, Cai, LY, Wu, H, Tang, L, Liu, JE, Deng, CY, Liu, YB, Zhu, Q, Li, HP, Hu, W, Yang, M, Zhu, YZ, Zhong, SL
Less
FRONTIERS IN PHARMACOLOGY[1663-9812],
Published 2021,
Volume 12,
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 4
2023影響因子:
4.4
发表年影響因子:
5.988
6.Regional Heterogeneity of Perivascular Adipose Tissue: Morphology, Origin, and Secretome
Li, XZ, Ma, ZY, Zhu,
More...
Li, XZ, Ma, ZY, Zhu, YZ
Less
FRONTIERS IN PHARMACOLOGY[1663-9812],
Published 2021,
Volume 12,
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 28
2023影響因子:
4.4
发表年影響因子:
5.988
7.Atezolizumab plus platinum-based chemotherapy as first-line therapy for metastatic urothelial cancer: A cost-effectiveness analysis
Liu, XY, Lang, YT, C
More...
Liu, XY, Lang, YT, Chai, QQ, Lin, Y, Liao, YH, Zhu, YZ
Less
FRONTIERS IN PHARMACOLOGY[1663-9812],
Published 2022,
Volume 13,
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 4
2023影響因子:
4.4
发表年影響因子:
5.6
8.Leonurine promotes the maturation of healthy donors and multiple myeloma patients derived-dendritic cells via the regulation on arachidonic acid metabolism
Chen, C, He, L, Wang
More...
Chen, C, He, L, Wang, X, Xiao, R, Chen, S, Ye, ZC, Wang, XM, Wang, Y, Zhu, YZ, Dai, JY
Less
FRONTIERS IN PHARMACOLOGY[1663-9812],
Published 2023,
Volume 14,
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 3
2023影響因子:
4.4
发表年影響因子:
4.4
9.Plasma metabolomic profiling reveals factors associated with dose-adjusted trough concentration of tacrolimus in liver transplant recipients
Zhu, HJ, Wang, M, Xi
More...
Zhu, HJ, Wang, M, Xiong, XF, Du, Y, Li, DY, Wang, Z, Ge, WH, Zhu, YZ
Less
FRONTIERS IN PHARMACOLOGY[1663-9812],
Published 2022,
Volume 13,
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 3
2023影響因子:
4.4
发表年影響因子:
5.6
10.Research progress of interleukin-15 in cancer immunotherapy
Cai, Menghan, Huang,
More...
Cai, Menghan, Huang, Xuan, Huang, Xiting, Ju, Dianwen, Zhu, Yi Zhun, Ye, Li
Less
Frontiers in Pharmacology[1663-9812],
Published 2023,
Volume 14,
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 13
2023影響因子:
4.4
发表年影響因子:
4.4
11.Identification of polyunsaturated fatty acids as potential biomarkers of osteoarthritis after sodium hyaluronate and mesenchymal stem cell treatment through metabolomics
Yang, QY, Zhao, YR,
More...
Yang, QY, Zhao, YR, Li, N, Wu, JL, Huang, XL, Zhang, M, Bian, XQ, Zhu, YZ
Less
FRONTIERS IN PHARMACOLOGY[1663-9812],
Published 2023,
Volume 14,
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 2
2023影響因子:
4.4
发表年影響因子:
4.4
12.A comprehensive review of Siraitia grosvenorii (Swingle) C. Jeffrey: chemical composition, pharmacology, toxicology, status of resources development, and applications
Huang, HX, Peng, Z,
More...
Huang, HX, Peng, Z, Zhan, S, Li, W, Liu, D, Huang, SR, Zhu, YZ, Wang, W
Less
FRONTIERS IN PHARMACOLOGY[1663-9812],
Published 2024,
Volume 15,
收錄情况：
WOS
SCOPUS
WOS核心合集引用: 0
2023影響因子:
4.4
